JENA, Germany — Carl Zeiss Meditec reported revenues of €431.8 million for the first 6 months of the fiscal year, an increase of 14.8% over the same period in the prior fiscal year, according to a company press release.
The company’s earnings before interest and taxes increased by 19%, from €51.3 million to €61.1 million, the release said.
"I am particularly delighted that we achieved very profitable growth," Ludwin Monz, PhD, MBA, president and CEO of Carl Zeiss Meditec, said in the release. “The half-year result is an endorsement of our strategy to strengthen our broad business portfolio with innovations and to grow on a global scale."
The company’s ophthalmic systems accounted for the smallest gain among its strategic business units, growing by 6.6%, the release said. The surgical ophthalmology unit experienced 14.8% growth, while the microsurgery unit grew 23.9%.
The company is forecasting continued growth for the remainder of the year but at a lower rate partly due to seasonal reasons, the release said.
"We are adhering to our target of achieving an [earnings before interest and taxes] margin of 15% by 2015,” Dr. Monz said.